Cite

HARVARD Citation

    Volz, B. et al. (n.d.). A new family of potent TLR9 agonists, EnanDIM, which inhibit tumor growth in various syngeneic murine models. European journal of cancer. pp. S5-S6. [Online]. 
  
Back to record